Cancer treatment during childbearing years increased risk of preterm birth and delivering low birth weight babies.
Increased risks among live births for adolescent and young adult cancer survivors
Pregnancy around the time of, or after, diagnosis of breast cancer is not associated with an increased risk of death.
Evidence suggests that women with myeloproliferative neoplasms have a higher risk of maternal and fetal complications. In this data analysis, researchers evaluated outcomes for pregnant women with essential thrombocythemia, polycythemia, or myelofibrosis and their infants.
Pregnancy screening rates before teratogenic exposures are low for female adolescent patients with acute leukemia and those with ER visits including abdominal/pelvic CT.
The BRCA1 mutation may speed the aging of a woman's ovaries,according to a recent report.
Among women aged up to 49 years with a pregnancy-associated melanoma, recurrence rates were higher than seen in other groups.
A recent study showed that women younger than 50 years who are pregnant or were recently pregnant at diagnosis of melanoma have a higher risk of death from the skin cancer.
Prenatal exposure to maternal cancer, with or without treatment, does not appear to impact early child development, a study found.
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy.
The risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is increased in women with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition.
Abnormal findings on early test don't always indicate birth defects, researchers say, but could instead indicate cancer.
Embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility for patients with breast cancer, according to a study published online.
Non-invasive prenatal testing (NIPT) can be employed as a less-invasive means to detect cancer in expecting mothers.
Breast cancer during pregnancy presents additional psychosocial challenges as patients cope with a devastating diagnosis during a time of hope and promise for the future.
Female meningioma survivors are more likely to want and to become pregnant than the general population, and some research indicates that pregnancy may be a risk factor for tumor progression or recurrence.
Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.
This fact sheet examines the relationship between oral contraception and risk of breast, ovarian, endometrial, liver, and cervical cancers.
International team assessed the impact of cancer treatment on children of women pregnant at diagnosis or during treatmentOctober 15, 2014
A number of oncologists hesitate to administer treatments to pregnant patients with cancer, due to concerns about the effect on the unborn.
Use of fertility drugs doesn't appear to increase a woman's long-term risk of breast, ovarian, and uterine cancers, new research indicates, but researchers still urge long-term monitoring.
A new study has found that the levonorgestrel-releasing intrauterine system, or progesterone-releasing IUD, may be associated with a higher than expected incidence of breast cancer.
Increased odds for spontaneous abortions, stillbirths, and ectopic pregnancies were seen for smokers, compared to never-smoking women.
Fertility concerns are common among young women with newly diagnosed breast cancer, although only a minority pursue fertility preservation strategies.
Linear dose-response relationship for acute lymphoblastic leukemia and acute myeloid leukemia has been observed.
Risk the same as found in women in the general population with regard to oral contraceptive use.
Hemodynamic changes associated with pregnancy explain the growth of benign tumors in pregnant women. The study also identified some key characteristics associated with rapid growth of meningiomas in pregnant women.
Adverse events more common for infants exposed to chemo in utero; mainly due to premature birth.
Men report routine sperm banking; however, women are rarely presented with fertility preserving options.
Exposure to antineoplastic drugs and sterilizing agents are linked with a significantly increased risk of miscarriage.
Relapse rates are the same regardless of estrogen receptor status of tumor.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|